Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 648

1.
2.

Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC.

PLoS One. 2010 May 7;5(5):e10527. doi: 10.1371/journal.pone.0010527.

PMID:
20479873
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.

Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, Rutherford G, Mermin J.

AIDS. 2007 Mar 30;21(6):713-9.

PMID:
17413692
[PubMed - indexed for MEDLINE]
5.

Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.

Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD.

PLoS One. 2012;7(3):e34156. doi: 10.1371/journal.pone.0034156. Epub 2012 Mar 30.

PMID:
22479548
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.

Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD.

PLoS One. 2013;8(2):e55824. doi: 10.1371/journal.pone.0055824. Epub 2013 Feb 13.

PMID:
23418463
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.

Bwire R, Nagelkerke NJ, Borgdorff MW.

Trop Med Int Health. 2006 Oct;11(10):1567-75.

PMID:
17002731
[PubMed - indexed for MEDLINE]
Free Article
8.

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.

Lawn SD, Myer L, Orrell C, Bekker LG, Wood R.

AIDS. 2005 Dec 2;19(18):2141-8.

PMID:
16284464
[PubMed - indexed for MEDLINE]
9.

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.

Lawn SD, Badri M, Wood R.

AIDS. 2005 Dec 2;19(18):2109-16.

PMID:
16284460
[PubMed - indexed for MEDLINE]
10.

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.

Moh R, Danel C, Messou E, Ouassa T, Gabillard D, Anzian A, Abo Y, Salamon R, Bissagnene E, Seyler C, Eholié S, Anglaret X.

AIDS. 2007 Nov 30;21(18):2483-91.

PMID:
18025885
[PubMed - indexed for MEDLINE]
11.

Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.

Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Vibhagool A.

J Infect. 2006 Mar;52(3):188-94. Epub 2005 Jun 29.

PMID:
15992932
[PubMed - indexed for MEDLINE]
12.

Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis.

Seyler C, Messou E, Gabillard D, Inwoley A, Alioum A, Anglaret X.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1338-47. doi: 10.1089/aid.2006.0308.

PMID:
18184075
[PubMed - indexed for MEDLINE]
13.

Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2.

van der Sande MA, Schim van der Loeff MF, Bennett RC, Dowling M, Aveika AA, Togun TO, Sabally S, Jeffries D, Adegbola RA, Sarge-Njie R, Jaye A, Corrah T, McConkey S, Whittle HC.

AIDS. 2004 Sep 24;18(14):1933-41.

PMID:
15353979
[PubMed - indexed for MEDLINE]
14.
15.

Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.

Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S.

J Infect. 2006 Dec;53(6):357-63. Epub 2006 Feb 17.

PMID:
16487593
[PubMed - indexed for MEDLINE]
16.

Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso.

Dembélé M, Saleri N, Carvalho AC, Saouadogo T, Hien AD, Zabsonre I, Koala ST, Simporé J, Matteelli A.

Int J Tuberc Lung Dis. 2010 Mar;14(3):318-23.

PMID:
20132623
[PubMed - indexed for MEDLINE]
17.

The tuberculosis challenge in a rural South African HIV programme.

Houlihan CF, Mutevedzi PC, Lessells RJ, Cooke GS, Tanser FC, Newell ML.

BMC Infect Dis. 2010 Feb 10;10:23. doi: 10.1186/1471-2334-10-23.

PMID:
20146818
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.

Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H; Swiss HIV Cohort Study.

Clin Infect Dis. 2007 Jan 1;44(1):94-102. Epub 2006 Nov 28.

PMID:
17143823
[PubMed - indexed for MEDLINE]
Free Article
19.

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL.

AIDS. 2002 Jan 4;16(1):75-83.

PMID:
11741165
[PubMed - indexed for MEDLINE]
20.

HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.

Martinson NA, Moultrie H, van Niekerk R, Barry G, Coovadia A, Cotton M, Violari A, Gray GE, Chaisson RE, McIntyre JA, Meyers T.

Int J Tuberc Lung Dis. 2009 Jul;13(7):862-7.

PMID:
19555536
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk